Pei Li
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 6
-
- Kidney Stones and Urolithiasis Treatments 8
- Ferroptosis and cancer prognosis 6
- Lung Cancer Treatments and Mutations 5
- Nephrology top 10%
-
- RNA modifications and cancer 5
- Cancer-related gene regulation 5
-
- Pediatric Urology and Nephrology Studies 5
- Co-authors
- Jianpeng GaoZhi‐Qiang LingTongxin YangJiongming LiLian‐Lian HongYanan QiGuang WangFan Wang
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Pei Li
82 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 178
- Pulmonary and Respiratory Medicine 270
- Oncology 175
- Immunology 134
- Nephrology 45
Countries citing papers authored by Pei Li
This map shows the geographic impact of Pei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Li more than expected).
Fields of papers citing papers by Pei Li
This network shows the impact of papers produced by Pei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Li. The network helps show where Pei Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 5 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 14 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 26 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 0 | |
| 15 | 2019 | 1 | |
| 16 | 2018 | 42 | |
| 17 | 2017 | 25 | |
| 18 | 2014 | 16 | |
| 19 | 2009 | 7 | |
| 20 | Comparing the Distribution of Genetic Polymorphism of MTHFR Thermolabile between Mongolian Population and Hans of China | 2000 | 1 |
About Pei Li
Pei Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Urology, having authored 89 papers that have together received 1.1k indexed citations. Recurring topics across this work include Kidney Stones and Urolithiasis Treatments (8 papers), Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers), Ferroptosis and cancer prognosis (6 papers), RNA modifications and cancer (5 papers), Cancer-related gene regulation (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Pediatric Urology and Nephrology Studies (5 papers). The work is most often cited by research in Cancer Research (178 citations), Pulmonary and Respiratory Medicine (270 citations) and Oncology (175 citations). Pei Li has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Jianpeng Gao, Zhi‐Qiang Ling, Tongxin Yang, Jiongming Li, Lian‐Lian Hong, Yanan Qi, Guang Wang, Fan Wang, Fengsen Li and Xuqi Li.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.